STOCKHOLM, Nov. 3, 2021 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced upcoming presentations concerning Nefecon, its lead product ...
“Aurinia is committed to growing the body of clinical research supporting LUPKYNIS as a safe and effective option for people with lupus who are fighting to protect their kidneys from the destructive ...
DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company committed to improving the lives of people suffering from serious diseases. DiaMedica’s lead candidate DM199 is the first ...
“We are excited to share these results and believe that the selection of nedosiran data for a late-breaker presentation at ASN Kidney Week underscores the importance of providing the medical community ...
Nephrologists recently gathered for the virtual American Society of Nephrology’s (ASN) Kidney Week 2021 to discuss the latest research, insights, and innovations in kidney care. This year’s conference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results